Literature DB >> 20176636

Interleukin-6: a therapeutic Jekyll and Hyde in gastrointestinal and hepatic diseases.

Silvio Danese1, Bin Gao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20176636      PMCID： PMC3732655          DOI： 10.1136/gut.2008.173534

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  16 in total

1.  The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.

Authors:  Christian Klein; Torsten Wüstefeld; Ulrike Assmus; Tania Roskams; Stefan Rose-John; Michael Müller; Michael P Manns; Mattias Ernst; Christian Trautwein
Journal:  J Clin Invest       Date:  2005-03-03       Impact factor: 14.808

Review 2.  Cytokines, STATs and liver disease.

Authors:  Bin Gao
Journal:  Cell Mol Immunol       Date:  2005-04       Impact factor: 11.530

3.  TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

Authors:  Christoph Becker; Massimo C Fantini; Christoph Schramm; Hans A Lehr; Stefan Wirtz; Alexei Nikolaev; Jürgen Burg; Susanne Strand; Ralf Kiesslich; Samuel Huber; Hiroaki Ito; Norihiro Nishimoto; Kazuyuki Yoshizaki; Tadamitsu Kishimoto; Peter R Galle; Manfred Blessing; Stefan Rose-John; Markus F Neurath
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

4.  Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease.

Authors:  Feng Hong; Svetlana Radaeva; Hong-na Pan; Zhigang Tian; Richard Veech; Bin Gao
Journal:  Hepatology       Date:  2004-10       Impact factor: 17.425

5.  In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats.

Authors:  Zhaoli Sun; Andrew S Klein; Svetlana Radaeva; Feng Hong; Osama El-Assal; Hong-Na Pan; Barbara Jaruga; Sandor Batkai; Sumito Hoshino; Zhigang Tian; George Kunos; Anna Mae Diehl; Bin Gao
Journal:  Gastroenterology       Date:  2003-07       Impact factor: 22.682

6.  A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease.

Authors:  Hiroaki Ito; Masakazu Takazoe; Yoshihiro Fukuda; Toshifumi Hibi; Kazuo Kusugami; Akira Andoh; Takayuki Matsumoto; Takehira Yamamura; Junichi Azuma; Norihiro Nishimoto; Kazuyuki Yoshizaki; Takashi Shimoyama; Tadamitsu Kishimoto
Journal:  Gastroenterology       Date:  2004-04       Impact factor: 22.682

7.  Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.

Authors:  Willscott E Naugler; Toshiharu Sakurai; Sunhwa Kim; Shin Maeda; Kyounghyun Kim; Ahmed M Elsharkawy; Michael Karin
Journal:  Science       Date:  2007-07-06       Impact factor: 47.728

8.  Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury.

Authors:  Norio Horiguchi; Lei Wang; Partha Mukhopadhyay; Ogyi Park; Won Il Jeong; Fouad Lafdil; Douglas Osei-Hyiaman; Akira Moh; Xin Yuan Fu; Pál Pacher; George Kunos; Bin Gao
Journal:  Gastroenterology       Date:  2008-01-11       Impact factor: 22.682

9.  Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms.

Authors:  Sanae Haga; Keita Terui; Hui Qi Zhang; Shin Enosawa; Wataru Ogawa; Hiroshi Inoue; Torayuki Okuyama; Kiyoshi Takeda; Shizuo Akira; Tetsuya Ogino; Kaikobad Irani; Michitaka Ozaki
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

Review 10.  Interleukin-6 and chronic inflammation.

Authors:  Cem Gabay
Journal:  Arthritis Res Ther       Date:  2006-07-28       Impact factor: 5.156
View more
  7 in total

1.  Chemokine CXCL11 links microbial stimuli to intestinal inflammation.

Authors:  Z Liu; X Chen; X Wang; X Chen; C-H Song; Y Du; J Su; S A Yaseen; P-C Yang
Journal:  Clin Exp Immunol       Date:  2011-03-25       Impact factor: 4.330

2.  Interleukin-6 inhibits apoptosis of exocrine gland tissues under inflammatory conditions.

Authors:  Jing Zhou; Jun-O Jin; Ekta S Patel; Qing Yu
Journal:  Cytokine       Date:  2015-08-05       Impact factor: 3.861

Review 3.  Pulmonary-intestinal cross-talk in mucosal inflammatory disease.

Authors:  S Keely; N J Talley; P M Hansbro
Journal:  Mucosal Immunol       Date:  2011-11-16       Impact factor: 7.313

4.  Effects of ammonia exposure on growth performance and cytokines in the serum, trachea, and ileum of broilers.

Authors:  Ying Zhou; Qing Xiu Liu; Xiu Mei Li; Dan Dan Ma; Shuang Xing; Jing Hai Feng; Min Hong Zhang
Journal:  Poult Sci       Date:  2020-03-19       Impact factor: 3.352

5.  Expression of Toll-like Receptors, Pro-, and Anti-inflammatory Cytokines in Relation to Gut Microbiota in Irritable Bowel Syndrome: The Evidence for Its Micro-organic Basis.

Authors:  Ratnakar Shukla; Ujjala Ghoshal; Prabhat Ranjan; Uday C Ghoshal
Journal:  J Neurogastroenterol Motil       Date:  2018-10-01       Impact factor: 4.924

Review 6.  Effect of Cigarette Smoke on Gut Microbiota: State of Knowledge.

Authors:  Xiaohua Gui; Zhongli Yang; Ming D Li
Journal:  Front Physiol       Date:  2021-06-17       Impact factor: 4.566

7.  An Autopsy Case of Multicentric Castleman Disease Presenting with Severe Jaundice.

Authors:  Yuichi Yamazaki; Yuka Yoshida; Megumi Shimizu; Takeshi Kobayashi; Hiroki Tojima; Ken Sato; Satoru Kakizaki; Hiroshi Handa; Hideaki Yokoo; Toshio Uraoka
Journal:  Intern Med       Date:  2021-06-05       Impact factor: 1.271
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.